Suppr超能文献

抗癌药物的致突变活性以及给予这些药物的大鼠的尿液。

The mutagenic activity of anti-cancer drugs and the urine of rats given these drugs.

作者信息

Pak K, Iwasaki T, Miyakawa M, Yoshida O

出版信息

Urol Res. 1979 Jun 22;7(2):119-24. doi: 10.1007/BF00254692.

Abstract

Twenty-one anti-cancer drugs have been tested for their ability to cause mutations in Salmonella typhimurium test strains in the Salmonella/microsome mutagenicity test. Nine of the 21 anticancer drugs showed this ability: cyclophosphmide, nitromin, thio-tepa, busulfan, 6-mercaptopurine, neocarzinostatin, daunomycin, adriamycin and estramustine phosphate. Seven of these 9 mutagenic drugs were injected continuously into the jugular veins of rats. Urine was collected through a cystostomy tube and tested for mutagenicity. The urine from rats treated with 6 of these 7 drugs was mutagenic. These were cyclophosphamide, nitromin, thio-tepa, neocarzinostatin, adriamycin and daunomycin.

摘要

在沙门氏菌/微粒体诱变性试验中,对21种抗癌药物进行了测试,以检测它们在鼠伤寒沙门氏菌试验菌株中引起突变的能力。这21种抗癌药物中有9种表现出这种能力:环磷酰胺、癌得命、塞替派、白消安、6-巯基嘌呤、新制癌菌素、柔红霉素、阿霉素和磷酸雌莫司汀。将这9种诱变药物中的7种连续注入大鼠颈静脉。通过膀胱造瘘管收集尿液并检测其诱变性。用这7种药物中的6种处理过的大鼠尿液具有诱变性。这些药物是环磷酰胺、癌得命、塞替派、新制癌菌素、阿霉素和柔红霉素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验